Abstract
Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Combinatorial Chemistry & High Throughput Screening
Title: Meet the Guest Editor
Volume: 8 Issue: 4
Author(s): Guido J.R. Zaman
Affiliation:
Abstract: Dr. Guido Zaman is Section Head Molecular in the Pharmacology Unit of N.V. Organon in Oss, the Netherlands. His section is responsible for assay development from cDNA to HTS, and in vitro biological testing from hit to clinical candidate. Guido completed his PhD in molecular biology on protein - RNA interaction at the University of Nijmegen in 1991, and studied multidrug resistance of human cancer cells at the Netherlands Cancer Institute in Amsterdam before joining Organon in 1996. In addition to serving as a guest editor of the mini-hot topic in this issue, Guido Zaman is a member of the Editorial Board of Assay & Drug Development Technologies.
Export Options
About this article
Cite this article as:
Zaman J.R. Guido, Meet the Guest Editor, Combinatorial Chemistry & High Throughput Screening 2005; 8 (4) . https://dx.doi.org/10.2174/1386207054020787
DOI https://dx.doi.org/10.2174/1386207054020787 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine
Current Drug Targets Isolation, Characterization and Preliminary Cytotoxic and Antifungal Evaluations of Novel Lancifoliate Isolated from Methanol Extract of <i>Conocarpus lancifolius</i>
Anti-Cancer Agents in Medicinal Chemistry An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Polyethylenimine-based Formulations for Delivery of Oligonucleotides
Current Medicinal Chemistry The Roles of Sox Family Genes in Sarcoma
Current Drug Targets Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Current Molecular Pharmacology Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
Current Computer-Aided Drug Design Cancer Proteomics: New Horizons and Insights into Therapeutic Applications
Current Proteomics Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Current Pharmaceutical Biotechnology In Utero Gene Therapy: Prospect and Future
Current Pharmaceutical Design Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients
Current HIV Research Kit: Molecule of Interest for the Diagnosis and Treatment of Mastocytosis and other Neoplastic Disorders
Current Cancer Drug Targets Sanguinarine: A Double-Edged Sword of Anticancer and Carcinogenesis and Its Future Application Prospect
Anti-Cancer Agents in Medicinal Chemistry Targeted Radiosensitization in Prostate Cancer
Current Pharmaceutical Design Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets